Pancreatic Cancer Research

ResearcherPudong New Area People's HospitalActive in the last 2 years

Yunfeng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8217-5776; OpenAlex author ID A5100626589. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 4

  1. The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer. Co-author DOI 10.1016/j.jare.2024.01.014↗
  2. TOPBP1 as a potential predictive biomarker for enhanced combinatorial efficacy of olaparib and AZD6738 in PDAC. Last author DOI 10.1186/s13578-025-01350-9↗
  3. Age-period-cohort analysis of global, regional, and national pancreatic cancer incidence, mortality, and disability-adjusted life years, 1990-2019. Co-author DOI 10.1186/s12885-024-12835-0↗
  4. Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer. First author DOI 10.1186/s12957-022-02785-x↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaomei Tang · 2 shared papers, 2025 · strength 0.42
  2. Zengfu Song · 1 shared paper, 2024 · strength 0.28
  3. Haoran Zhao · 1 shared paper, 2024 · strength 0.28
  4. Hong Yu · 1 shared paper, 2025 · strength 0.21
  5. Yizhi Cao · 1 shared paper, 2025 · strength 0.21
  6. Hong Jiang · 1 shared paper, 2025 · strength 0.21
  7. Haoyu Tang · 1 shared paper, 2025 · strength 0.21
  8. Da Fu · 1 shared paper, 2025 · strength 0.21
  9. Yu‐Shui Ma · 1 shared paper, 2025 · strength 0.21
  10. Jianli Su · 1 shared paper, 2022 · strength 0.20
  11. Shuying Li · 1 shared paper, 2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.